Sevoflurane does not increase intracranial pressure in hyperventilated dogs

Area of Science:

• Anesthesiology
• Neuroscience
• Veterinary Medicine

Background:

• Inhalational anesthetics are crucial for maintaining physiological stability during neurosurgery.
• Understanding the effects of anesthetics on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) is vital for patient safety.
• Sevoflurane is a widely used volatile anesthetic, but its effects on cerebral hemodynamics require thorough investigation.

Purpose of the Study:

• To evaluate the impact of sevoflurane on ICP, CPP, mean arterial pressure (MAP), central venous pressure, and heart rate in hypocapnic dogs.
• To compare these effects with those of equipotent concentrations of enflurane and halothane.
• To determine the suitability of sevoflurane for neuroanesthesia.

Main Methods:

• Measurements of ICP, CPP, MAP, central venous pressure, and heart rate were performed in hypocapnic dogs.
• Dogs were administered sevoflurane, enflurane, or halothane at end-tidal concentrations of 0.5, 1.0, and 1.5 MAC.
• Data were analyzed to compare the hemodynamic effects of the different anesthetic agents.

Main Results:

• Sevoflurane, at all tested concentrations, did not significantly alter ICP.
• Enflurane and halothane caused small but significant increases in ICP.
• Sevoflurane led to a considerable decrease in MAP and a consequent reduction in CPP.

Conclusions:

• Sevoflurane is a suitable agent for neuroanesthesia due to its lack of effect on ICP.
• Sevoflurane demonstrates a favorable profile compared to enflurane and halothane regarding ICP management.
• Careful monitoring of MAP and CPP is recommended during sevoflurane administration in neuroanesthesia due to potential decreases.